Abstract:Abstract Background The apolipoprotein E ε4 (APOE4) allele is a well‐established genetic risk factor for late‐onset Alzheimer disease (AD). There is strong evidence that APOE4 enhances amyloid accumulation and previous research in animal models have demonstrated that APOE4 promotes tau pathology independently of amyloid. In this study, we investigate the relationship between APOE4 and tau to see whether the relationship between APOE4 and tau is mediated by, independent of, or interacts with levels of amyloid. Method 347 participants from the Knight Alzheimer Disease Research Center (mean age = 69.7) underwent tau‐PET imaging with [ 18 F]‐flortaucipir and amyloid‐PET with [ 18 F]‐florbetapir within a year. Tau‐ and amyloid‐ PET data were converted to standardized uptake value ratios (SUVRs) for each region of interest. A summary amyloid measure was calculated for statistical analysis using the average of lateral orbitofrontal, medial orbitofrontal, rostral middle frontal, superior frontal, superior temporal, middle temporal, and precuneus regions. APOE4 carrier status was defined by the presence of at least one ε4 allele. We ran three separate linear models for our analysis. First we examined the APOE4‐tau and the amyloid‐tau relationship with model 1 predicting regional tau using amyloid, age, and sex as predictors and model 2 predicting regional tau using APOE4 status, age, and sex as predictors. Next we examined the relationship between tau and both APOE4 and amyloid in concert with model 3 predicting regional tau using amyloid, APOE4 status, an interaction between amyloid and APOE4 status, sex, and age as predictors. Result We found that the amyloid‐tau relationship was widespread throughout the brain and the APOE4‐tau relationship was predominately in the inferior parietal and temporal pole regions (figure 1). Most importantly, we found a significant APOE4 status and amyloid interaction that was most prominent in the entorhinal cortex and superior temporal regions (figure 2). Conclusion Our results show that there is a significant effect of APOE4 status and tau deposition that is above and beyond the effect of APOE4 on amyloid. This relationship is synergetic, where E4 carriers have more tau pathology for the same levels of amyloid deposition as non‐carriers.

Effect of Truncated-Apoe4 Overexpression on Tau Phosphorylation in Cultured N2a Cells.

Effect of truncated apolipoprotein E4 on the neurofilament phosphorylation in cultured neurons

P3‐309: Overexpression of Hyperphosphorylated Tau Antagonizes Aβ‐potentiated Apoptosis with Preservation of Mitochondrial Elements

Defects in the autophagy lysosomal pathway in a cell model of disease‐associated tau

Effects of Endogenous Β‐amyloid Overproduction on Tau Phosphorylation in Cell Culture

Tau Protein Antagonizes Cell Apoptosis Through Akt Pathway

Neuronal apolipoprotein E4 increases cell death and phosphorylated tau release in alzheimer disease

Endogenous Overproduction of Β-Amyloid Induces Tau Hyperphosphorylation and Decreases the Solubility of Tau in N2a Cells

The Effect Ofcdk-5 Overexpression and Overactivation on Tau Hyperphosphorylation in Cultured N2a Cells

Intracerebral Expression of AAV-APOE4 Is Not Sufficient to Alter Tau Burden in Two Distinct Models of Tauopathy

Impact of APOE genotype on prion-type propagation of tauopathy

The influence of APOEε4 on the pTau interactome in sporadic Alzheimer's disease

Overexpression Of Tau Proteins Antagonizes Amyloid-Beta-Potentiated Apoptosis Through Mitochondria-Caspase-3 Pathway In N2a Cells

Effect of CDK-5 Overexpression on Tau Phosphorylation

Neuronal APOE4 removal protects against tau-mediated gliosis, neurodegeneration and myelin deficits

APOE4 status influences the amyloid and tau relationship

Protective Effects Of Erythropoietin On Tau Phosphorylation Induced By Beta-Amyloid

Opposing effects of viral mediated brain expression of apolipoprotein E2 (apoE2) and apoE4 on apoE lipidation and Aβ metabolism in apoE4-targeted replacement mice

Selective removal of astrocytic APOE4 strongly protects against tau-mediated neurodegeneration and decreases synaptic phagocytosis by microglia

APOE4-specific Changes in Aβ Accumulation in a New Transgenic Mouse Model of Alzheimer Disease

ApoE4 expression disrupts tau uptake, trafficking, and clearance in astrocytes